Clinical-stage biotherapeutics company PureTech Health launched a proposed $100m tender offer on Monday, aiming to repurchase shares at a fixed price of 250p each, or £25.00 per American depositary share (ADS).
London stocks were still in the black by midday on Monday, with miners pacing the gains as gold and copper prices jumped, as investors mulled dovish comments from the Bank of England’s Deputy Governor and looked ahead to key inflation data later in the week.
PureTech Health (NASDAQ:PRTC) Shares Gap Down to $28 51 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.